Healthtech Startups

Cell BioEngines is a clinical-stage biotech company developing allogeneic "off-the-shelf" cell therapies from "super donor" stem cells, using transgene-free scalable manufacturing and HLA-guided design. It pursues stem cell-derived therapeutics across oncology and regenerative medicine.

1 investor

Cellbox Solutions develops portable incubators with active CO₂ and temperature control to transport living cells and biological samples at constant laboratory conditions (37°C, 5% CO₂). The company serves the global biomedical industry and works with over 150 customers on cell transport logistics.

1 investor

CellBri provides modular, automated cell processing systems for preparing cells for therapeutic applications. The company offers enclosed, turnkey solutions that can automate individual steps or complete workflows, from cell harvesting and separation through expansion and cryopreservation.

1 investor

CellCarta is a contract research organization providing biomarker discovery, assay development, and clinical trial execution services for pharmaceutical companies and biotechs. It offers multi-omic biomarker insights, regulatory-ready data generation, and regulatory support for assay development and IVDR submissions across preclinical and clinical therapeutic programs.

1 investor

Celldex is a biotechnology company developing therapeutics across therapeutic areas including immunology and inflammation. The page shown is a board director biography rather than a company overview.

1 investor

Cellectis is a biotech company focused on cell therapy and immunotherapy. The company is publicly listed on Nasdaq and Euronext Growth Paris.

1 investor

Cellera Farma is a Brazilian pharmaceutical company that manages a portfolio of established medical products through partnerships, licensing, distribution, promotion, and proprietary products. It focuses on therapeutic areas including central nervous system, gastroenterology, orthopedics, and pediatrics.

1 investor

Cellergy Pharma develops immunotherapies for patients with severe allergic disease and cancer.

1 investor

IngenOx Therapeutics is a clinical-stage biopharmaceutical company developing precision drugs and cancer vaccines for patients with advanced, treatment-resistant cancers that evade the immune system. Based in Oxford, UK, it uses an in-house discovery platform for both small-molecule drug development and vaccine development targeting immunologically cold tumours.

1 investor

Cellestial Health is a preclinical-stage biotech developing therapies for Parkinson's disease, with a lead candidate rooted in astrocytic network biology. The company focuses on drug discovery for neurological disease.

1 investor

Cellipont Bioservices is a contract development and manufacturing organization (CDMO) that provides GMP manufacturing and development services for advanced cell therapies. It serves pharma and biotech clients developing cell therapy treatments.

1 investor

Cellpurics is a South Korean biotech company focused on stem cell technologies, including large-scale gonadal stem cell cultivation and storage, Real-time PCR-based measurement of mesenchymal stem cell anti-inflammatory capacity, and high-tech companion animal diagnostics. It also provides contract research organization (CRO) services covering in vitro and in vivo drug efficacy evaluation, veterinary drug and medical device clinical trials, GLP toxicity testing, and AI-based drug discovery.

1 investor

A biotech company developing cell and gene technology solutions focused on regenerative medicine and advancing healthcare innovations.

1 investor

CellTivity Scientific provides point-of-care biopsy assessment technology to improve cancer diagnosis accuracy and speed. The company aims to reduce diagnostic delays and uncertainty while preparing samples for next-generation sequencing.

1 investor

CellTrack develops a cell-labeling technology that attaches Zirconium-89 to therapeutic cells for non-invasive PET imaging, allowing tracking of cell biodistribution in vivo for over 7 days. The company targets pharma companies and CDMOs developing cell therapies, aiming to provide biodistribution data for clinical trials.

1 investor

Celltrio manufactures robotic automation systems for the life sciences industry, with patented technology for biobanking and cell culturing automation. The company licenses IP from a Korean robotics partner and develops products with a US-based engineering team.

1 investor

Cellumed is a South Korean biotech company focused on musculoskeletal medical devices and biological products. It also develops and supplies growth factors and production enzymes used for RNA vaccines and therapeutics.

1 investor

Cellview develops the WRI-1, a widefield non-mydriatic retinal imaging device that captures up to 133° in a single image and auto-stitches up to 200° for retinal periphery screening. The system is designed for eye care professionals to image patients including those with small pupils, cataracts, or other media opacities.

1 investor

Celmatix Therapeutics developed a discovery portfolio focused on women's health, including therapeutic programs for infertility, endometriosis, and ovarian aging. The company's pipeline included an oral FSH receptor agonist, a JNK inhibitor, and AMH-targeting antibodies.

1 investor

Celo is a secure messaging and collaboration platform for healthcare care teams, available on iPhone, Android, and web. It is used by healthcare organizations and individuals to communicate while safeguarding patient data.

1 investor

Centaur Pharmaceuticals is an integrated Indian pharmaceutical company operating across active pharmaceutical ingredients (APIs), finished formulations, clinical research, and contract manufacturing, with distribution reaching 120 countries. It manufactures psychotropic APIs and branded formulations such as the anti-cold brand Sinarest, and conducts clinical trials through its LifeSan research arm.

1 investor

Center for Youth Wellness provides mental health resources, education, and advocacy for young people, focusing on trauma-informed care and holistic well-being through educational initiatives and community partnerships.

1 investor

CenterPointe Hospital provides inpatient, residential, and outpatient behavioral healthcare for adults and senior adults dealing with mental health conditions and substance use disorders. It is located in St. Charles, Missouri.

1 investor

Lifepoint is a diversified healthcare delivery network operating community hospitals, rehabilitation and behavioral health hospitals, and additional sites of care across the healthcare continuum. Founded in 1999, it operates facilities across 34 U.S. states.

1 investor